Brian Nowosielski

Observed by APhA and ASHP since 2023, bipartisan support has garnered to give pharmacy workforce suicide awareness its own federally recognized day.

Chad Worz, PharmD, BCGP, FASCP, discusses the Main Street Pharmacy Access Act, a revolutionary pharmacy-focused bill moving through Congress.

Researchers assess the neurological outcomes of over 200,000 children exposed to COVID-19 before birth.

Researchers assess the differences in out-of-pocket spending on brand name compared with generic medication.

Starting with Exelixis’ condition on in-house dispensing data, manufacturers are introducing a new approach to 340B claims focused on transparency.

Digital innovation and proactive patient care are converging to transform clinical practice while preserving essential safeguards.

As pouched products increase in popularity, researchers assess their pharmacology, harm-reduction potential, and initiation risk.

Madeline Sutton, MD, MPH, FACOG, joins to discuss risks of HPV infection among women and how pharmacists can improve outcomes in this area.

In part 2, Vanessa Slowey explains the pharmacy industry’s need for due diligence as technology reinforces patient convenience in the 21st century.

As pharmacists vocalize their willingness to fill in health care gaps, the integration of public health and emerging pharmacy professionals could be profound.

A persistence of pneumococcal meningitis among adults transformed the disease into a public health concern pharmacists fight on a population-wide scale.

In this episode, Shawn Bjorndal, PharmD, RPh, and Jesse McCullough, PharmD, explore rhythms, routines and how they can make or break pharmacy team members.

Vanessa Slowey lays the ground for where AI and automation are impacting pharmacy practice today and discusses what innovations are still expected.

Among patients with type 2 diabetes, researchers explore the effects of selecting additional therapy for GLP-1 treatment.

Thomas Lew, MD, ABIM, Molly O’Shea, MD, FAAP, and Jesse Goodman, MD, MPH, discuss vaccine policy changes and their impact on measles outbreaks.

Jesse Goodman, MD, MPH, provides nuance regarding HHS’ suggestion to separate MMR combination vaccines as well as the looming elimination status review in November.

Once-weekly basal insulin has moved from an intriguing possibility to a new clinical reality.

Molly O’Shea, MD, FAAP, shares insights on MMR coverage, measles outbreaks, and the pharmacist’s role from the perspective of a pediatrician.

In part 1 of our series, Thomas Lew, MD, ABIM, explores the optimal approaches to meandering vaccine hesitancy amid increasing measles cases.

For patients living with ASCVD, researchers find the optimal approach for ensuring medication adherence within patients’ statin regimens.

Presenting what they believe are the problems and solutions, PCMA CEO David Marin and NCPA CEO Douglas Hoey, RPh, discuss the US drug pricing dilemma.

The 4 key organizations regularly focusing on respiratory virus season released updated vaccine recommendations for 2026-2027.

Scott Stoll and Kenzie Hohman, PharmD, discuss the importance of pharmacy advocacy, from localized efforts to federal movement across the profession.

The American Pharmacists Association, Canadian Pharmacists Association, and International Pharmaceutical Federation release plans for pharmacists’ primary care integration.

JD Power releases its US Pharmacy Digital Experience Study, highlighting the growing importance of digital solutions in pharmacy practice and business.

In part 2, Scott Stoll and Kenzie Hohman, PharmD, explain their respective advocacy efforts, highlighting the sheer range of a profession fighting for change.

Kenzie Hohman, PharmD, and Scott Stoll believe pharmacy advocacy is inherent in its workforce, despite the constant and deterrent pressures it faces.

The federal government is actively looking to enhance its evolving approach toward US childhood vaccine recommendations.

With previous approvals for weight loss and sleep apnea, tirzepatide is opening doors to a healthier well-being for patients living with type 2 diabetes.

This fall’s event will focus on the expanding role of pharmacists in providing patient care with clinical value, prevention, and more.